Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Nierengarten's Stock Ratings
Wedbush Analyst
David Nierengarten is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2025
Overall Average Return
8.11%
Smart Score
Overall Average Return Percentile
60th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/16/2025 | NVCR | Buy Now | NovoCure | $18.75 | 44% | David Nierengarten63% | $29 → $27 | Maintains | Neutral | Get Alert |
| 04/16/2025 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $21.64 | 57.12% | David Nierengarten63% | $34 → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 04/16/2025 | ARGX | Buy Now | argenx | $614.76 | 16.31% | David Nierengarten63% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert |
| 04/16/2025 | BPMC | Buy Now | Blueprint Medicines | $87.02 | 47.09% | David Nierengarten63% | $128 → $128 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2025 | ARGX | Buy Now | argenx | $614.76 | 16.31% | David Nierengarten63% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert |
| 03/27/2025 | CATX | Buy Now | Perspective Therapeutics | — | — | David Nierengarten63% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2025 | IMNM | Buy Now | Immunome | $8.45 | 290.53% | David Nierengarten63% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 03/14/2025 | STRO | Buy Now | Sutro Biopharma | $0.91 | 119.8% | David Nierengarten63% | $8 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 03/06/2025 | FATE | Buy Now | Fate Therapeutics | $1.28 | 290.62% | David Nierengarten63% | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 02/12/2025 | BCAX | Buy Now | Bicara Therapeutics | $14.54 | 113.2% | David Nierengarten63% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | 72.07% | David Nierengarten63% | $77 → $77 | Reiterates | Outperform → Outperform | Get Alert |
| 02/07/2025 | ANAB | Buy Now | AnaptysBio | $20.70 | 93.24% | David Nierengarten63% | $40 → $40 | Maintains | Outperform | Get Alert |
| 02/06/2025 | BCAX | Buy Now | Bicara Therapeutics | $14.54 | 113.2% | David Nierengarten63% | → $31 | Initiates | → Outperform | Get Alert |
| 01/13/2025 | BPMC | Buy Now | Blueprint Medicines | $87.02 | 42.5% | David Nierengarten63% | $135 → $124 | Reiterates | Outperform → Outperform | Get Alert |
| 12/02/2024 | APGE | Buy Now | Apogee Therapeutics | $36.85 | 144.23% | David Nierengarten63% | $87 → $90 | Maintains | Outperform | Get Alert |
| 11/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | 43.25% | David Nierengarten63% | $40 → $47 | Maintains | Outperform | Get Alert |
| 11/18/2024 | CMRX | Buy Now | Chimerix | $8.54 | -29.74% | David Nierengarten63% | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert |
| 11/18/2024 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | 64.71% | David Nierengarten63% | $14 → $14 | Reiterates | Neutral → Neutral | Get Alert |
| 10/25/2024 | APGE | Buy Now | Apogee Therapeutics | $36.85 | 136.09% | David Nierengarten63% | $87 → $87 | Reiterates | Outperform → Outperform | Get Alert |
| 10/25/2024 | IMNM | Buy Now | Immunome | $8.45 | 290.53% | David Nierengarten63% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | David Nierengarten63% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 10/22/2024 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 10/07/2024 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | 12.77% | David Nierengarten63% | $27 → $37 | Maintains | Outperform | Get Alert |
| 10/01/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | David Nierengarten63% | → $25 | Initiates | → Outperform | Get Alert |
| 09/30/2024 | INZY | Buy Now | Inozyme Pharma | $0.96 | 1467.4% | David Nierengarten63% | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 09/26/2024 | ANAB | Buy Now | AnaptysBio | $20.70 | 102.9% | David Nierengarten63% | $42 → $42 | Reiterates | Outperform → Outperform | Get Alert |
| 09/16/2024 | NUVL | Buy Now | Nuvalent | $73.48 | 56.51% | David Nierengarten63% | $99 → $115 | Maintains | Outperform | Get Alert |
| 09/11/2024 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.10 | 460.98% | David Nierengarten63% | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 292.16% | David Nierengarten63% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 09/09/2024 | NUVL | Buy Now | Nuvalent | $73.48 | 34.73% | David Nierengarten63% | $99 → $99 | Reiterates | Outperform → Outperform | Get Alert |
| 09/04/2024 | ORKA | Buy Now | Oruka Therapeutics | $10.09 | 296.43% | David Nierengarten63% | → $40 | Initiates | → Outperform | Get Alert |
| 09/04/2024 | SYRE | Buy Now | Spyre Therapeutics | $14.13 | 218.47% | David Nierengarten63% | → $45 | Initiates | → Outperform | Get Alert |
| 08/13/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 292.16% | David Nierengarten63% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | TCRX | Buy Now | TScan Therapeutics | $1.60 | 525% | David Nierengarten63% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | IMNM | Buy Now | Immunome | $8.45 | 290.53% | David Nierengarten63% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | ARTV | Buy Now | Artiva Biotherapeutics | $2.35 | 665.96% | David Nierengarten63% | → $18 | Initiates | → Outperform | Get Alert |
| 08/09/2024 | IRON | Buy Now | Disc Medicine | $45.42 | 25.5% | David Nierengarten63% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2024 | GBIO | Buy Now | Generation Bio | $0.42 | 1095.03% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2024 | INZY | Buy Now | Inozyme Pharma | $0.96 | 1467.4% | David Nierengarten63% | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2024 | ARGX | Buy Now | argenx | $614.76 | -8.91% | David Nierengarten63% | $519 → $560 | Maintains | Outperform | Get Alert |
| 07/23/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $21.64 | 57.12% | David Nierengarten63% | $30 → $34 | Maintains | Outperform | Get Alert |
| 07/22/2024 | ARGX | Buy Now | argenx | $614.76 | -15.58% | David Nierengarten63% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
| 07/17/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 292.16% | David Nierengarten63% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 07/17/2024 | ARGX | Buy Now | argenx | $614.76 | -15.58% | David Nierengarten63% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
| 07/01/2024 | ARGX | Buy Now | argenx | $614.76 | -15.58% | David Nierengarten63% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
| 06/27/2024 | TSVT | Buy Now | 2seventy bio | $4.99 | 0.2% | David Nierengarten63% | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 06/26/2024 | ARGX | Buy Now | argenx | $614.76 | -15.58% | David Nierengarten63% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
| 05/29/2024 | IKNA | Buy Now | Ikena Oncology | $1.19 | 68.07% | David Nierengarten63% | $8 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 05/24/2024 | COGT | Buy Now | Cogent Biosciences | $4.67 | 114.13% | David Nierengarten63% | $10 → $10 | Reiterates | Neutral → Neutral | Get Alert |
| 05/24/2024 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 05/17/2024 | NUVL | Buy Now | Nuvalent | $73.48 | 34.73% | David Nierengarten63% | $99 → $99 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2024 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | STRO | Buy Now | Sutro Biopharma | $0.91 | 779.22% | David Nierengarten63% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | IKNA | Buy Now | Ikena Oncology | $1.19 | 572.27% | David Nierengarten63% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | GBIO | Buy Now | Generation Bio | $0.42 | 1095.03% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | VOR | Buy Now | Vor Biopharma | $0.76 | 1355.41% | David Nierengarten63% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | ANAB | Buy Now | AnaptysBio | $20.70 | 64.25% | David Nierengarten63% | → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | XNCR | Buy Now | Xencor | $10.51 | 242.53% | David Nierengarten63% | $34 → $36 | Maintains | Outperform | Get Alert |
| 05/10/2024 | FATE | Buy Now | Fate Therapeutics | $1.28 | 290.62% | David Nierengarten63% | $7 → $5 | Maintains | Neutral | Get Alert |
| 05/06/2024 | FATE | Buy Now | Fate Therapeutics | $1.28 | 446.88% | David Nierengarten63% | $7 → $7 | Reiterates | Neutral → Neutral | Get Alert |
| 04/26/2024 | BPMC | Buy Now | Blueprint Medicines | $87.02 | 26.41% | David Nierengarten63% | $110 → $110 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2024 | BEAM | Buy Now | Beam Therapeutics | $19.52 | 192.01% | David Nierengarten63% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2024 | VOR | Buy Now | Vor Biopharma | $0.76 | 1355.41% | David Nierengarten63% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2024 | TCRX | Buy Now | TScan Therapeutics | $1.60 | 525% | David Nierengarten63% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2024 | PRME | Buy Now | Prime Medicine | $1.75 | 585.71% | David Nierengarten63% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2024 | FATE | Buy Now | Fate Therapeutics | $1.28 | 446.88% | David Nierengarten63% | $7 → $7 | Reiterates | Neutral → Neutral | Get Alert |
| 04/23/2024 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | 241.18% | David Nierengarten63% | $29 → $29 | Reiterates | Neutral → Neutral | Get Alert |
| 04/18/2024 | ARGX | Buy Now | argenx | $614.76 | -15.25% | David Nierengarten63% | $521 → $521 | Reiterates | Outperform → Outperform | Get Alert |
| 04/03/2024 | PRME | Buy Now | Prime Medicine | $1.75 | 585.71% | David Nierengarten63% | → $12 | Initiates | → Outperform | Get Alert |
| 04/02/2024 | PRME | Buy Now | Prime Medicine | $1.75 | 585.71% | David Nierengarten63% | → $12 | Initiates | → Outperform | Get Alert |
| 04/01/2024 | IMNM | Buy Now | Immunome | $8.45 | 290.53% | David Nierengarten63% | $27 → $33 | Maintains | Outperform | Get Alert |
| 03/26/2024 | STRO | Buy Now | Sutro Biopharma | $0.91 | 779.22% | David Nierengarten63% | $12 → $8 | Maintains | Outperform | Get Alert |
| 03/21/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | David Nierengarten63% | $24 → $24 | Reiterates | Neutral → Neutral | Get Alert |
| 03/21/2024 | VOR | Buy Now | Vor Biopharma | $0.76 | 1355.41% | David Nierengarten63% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | BLUE | Buy Now | bluebird bio | $4.18 | -59.81% | David Nierengarten63% | $60 → $33.6 | Maintains | Neutral | Get Alert |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | David Nierengarten63% | → $24 | Downgrade | Outperform → Neutral | Get Alert |
| 03/18/2024 | TSVT | Buy Now | 2seventy bio | $4.99 | 0.2% | David Nierengarten63% | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 292.16% | David Nierengarten63% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | ANAB | Buy Now | AnaptysBio | $20.70 | — | David Nierengarten63% | $20 → $34 | Upgrade | Neutral → Outperform | Get Alert |
| 03/07/2024 | GBIO | Buy Now | Generation Bio | $0.42 | 1095.03% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 292.16% | David Nierengarten63% | $12 → $20 | Maintains | Outperform | Get Alert |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 1824.66% | David Nierengarten63% | $2 → $7 | Upgrade | Neutral → Outperform | Get Alert |
| 02/28/2024 | XNCR | Buy Now | Xencor | $10.51 | 223.5% | David Nierengarten63% | $36 → $34 | Maintains | Outperform | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $1.28 | 446.88% | David Nierengarten63% | $3 → $7 | Maintains | Neutral | Get Alert |
| 02/26/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | 56.42% | David Nierengarten63% | $60 → $70 | Maintains | Outperform | Get Alert |
| 02/23/2024 | COGT | Buy Now | Cogent Biosciences | $4.67 | 114.13% | David Nierengarten63% | $5 → $10 | Maintains | Neutral | Get Alert |
| 02/13/2024 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | $5 → $4 | Maintains | Outperform | Get Alert |
| 02/01/2024 | TCRX | Buy Now | TScan Therapeutics | $1.60 | 462.5% | David Nierengarten63% | $9 → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | INZY | Buy Now | Inozyme Pharma | $0.96 | 1467.4% | David Nierengarten63% | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 01/26/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | David Nierengarten63% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2024 | IMNM | Buy Now | Immunome | $8.45 | 124.85% | David Nierengarten63% | $12 → $19 | Maintains | Outperform | Get Alert |
| 01/19/2024 | IKNA | Buy Now | Ikena Oncology | $1.19 | 572.27% | David Nierengarten63% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 01/18/2024 | VOR | Buy Now | Vor Biopharma | $0.76 | 1355.41% | David Nierengarten63% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 01/17/2024 | KNTE | Buy Now | Kinnate Biopharma | — | — | David Nierengarten63% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 01/02/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $21.64 | 15.53% | David Nierengarten63% | $23 → $25 | Maintains | Outperform | Get Alert |
| 12/19/2023 | IMNM | Buy Now | Immunome | $8.45 | 42.01% | David Nierengarten63% | → $12 | Initiates | → Outperform | Get Alert |
| 12/11/2023 | COGT | Buy Now | Cogent Biosciences | $4.67 | 7.07% | David Nierengarten63% | $20 → $5 | Downgrade | Outperform → Neutral | Get Alert |
| 12/08/2023 | MAXN | Buy Now | Maxeon Solar Technologies | $3.40 | 47.06% | David Nierengarten63% | $1400 → $500 | Maintains | Equal-Weight | Get Alert |
| 11/29/2023 | ANAB | Buy Now | AnaptysBio | $20.70 | -3.38% | David Nierengarten63% | → $20 | Reiterates | Neutral → Neutral | Get Alert |
| 11/20/2023 | TSVT | Buy Now | 2seventy bio | $4.99 | -59.92% | David Nierengarten63% | → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 11/10/2023 | GBIO | Buy Now | Generation Bio | $0.42 | 2051.05% | David Nierengarten63% | $11 → $9 | Maintains | Outperform | Get Alert |
| 11/09/2023 | FATE | Buy Now | Fate Therapeutics | $1.28 | 134.38% | David Nierengarten63% | $6 → $3 | Maintains | Neutral | Get Alert |
| 11/08/2023 | XNCR | Buy Now | Xencor | $10.51 | 242.53% | David Nierengarten63% | $37 → $36 | Maintains | Outperform | Get Alert |
| 11/03/2023 | ANAB | Buy Now | AnaptysBio | $20.70 | -3.38% | David Nierengarten63% | $18 → $20 | Maintains | Neutral | Get Alert |
| 10/30/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 10/23/2023 | STRO | Buy Now | Sutro Biopharma | $0.91 | 1218.83% | David Nierengarten63% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 10/23/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 174.51% | David Nierengarten63% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 10/18/2023 | FRLN | Buy Now | Freeline Therapeutics | — | — | David Nierengarten63% | $8 → $5 | Downgrade | Outperform → Neutral | Get Alert |
| 10/18/2023 | ITOS | Buy Now | ITeos Therapeutics | $7.35 | 348.98% | David Nierengarten63% | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 09/22/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.10 | 174.51% | David Nierengarten63% | → $14 | Initiates | → Outperform | Get Alert |
| 09/22/2023 | IKNA | Buy Now | Ikena Oncology | $1.19 | 824.37% | David Nierengarten63% | → $11 | Initiates | → Outperform | Get Alert |
| 09/19/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | David Nierengarten63% | $14 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 09/08/2023 | INZY | Buy Now | Inozyme Pharma | $0.96 | 1467.4% | David Nierengarten63% | → $15 | Maintains | Outperform | Get Alert |
| 08/17/2023 | CMRX | Buy Now | Chimerix | $8.54 | -29.74% | David Nierengarten63% | → $6 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | STRO | Buy Now | Sutro Biopharma | $0.91 | 1218.83% | David Nierengarten63% | $20 → $12 | Maintains | Outperform | Get Alert |
| 08/11/2023 | VOR | Buy Now | Vor Biopharma | $0.76 | 1355.41% | David Nierengarten63% | $18 → $11 | Maintains | Outperform | Get Alert |
| 08/10/2023 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | -26.85% | David Nierengarten63% | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2023 | ANAB | Buy Now | AnaptysBio | $20.70 | 25.6% | David Nierengarten63% | $29 → $26 | Maintains | Neutral | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $36.85 | 8.55% | David Nierengarten63% | → $40 | Initiates | → Outperform | Get Alert |
| 08/03/2023 | GBIO | Buy Now | Generation Bio | $0.42 | 2529.06% | David Nierengarten63% | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | TSVT | Buy Now | 2seventy bio | $4.99 | 340.88% | David Nierengarten63% | $26 → $22 | Maintains | Outperform | Get Alert |
| 07/27/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 449.9% | David Nierengarten63% | $12 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | -29.82% | David Nierengarten63% | $105 → $60 | Maintains | Neutral | Get Alert |
| 07/20/2023 | NUVL | Buy Now | Nuvalent | $73.48 | -27.87% | David Nierengarten63% | → $53 | Reiterates | Outperform → Outperform | Get Alert |
| 07/18/2023 | ARGX | Buy Now | argenx | $614.76 | -7.28% | David Nierengarten63% | → $570 | Reiterates | Outperform → Outperform | Get Alert |
| 07/14/2023 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | David Nierengarten63% | $24 → $7 | Maintains | Outperform | Get Alert |
| 07/13/2023 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | -26.85% | David Nierengarten63% | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 07/12/2023 | AVRO | Buy Now | Avrobio | — | — | David Nierengarten63% | → $24 | Downgrade | Outperform → Neutral | Get Alert |
| 06/28/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | David Nierengarten63% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 06/22/2023 | TCRX | Buy Now | TScan Therapeutics | $1.60 | 400% | David Nierengarten63% | → $8 | Initiates | → Outperform | Get Alert |
| 06/21/2023 | ARGX | Buy Now | argenx | $614.76 | -26.15% | David Nierengarten63% | → $454 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2023 | NVCR | Buy Now | NovoCure | $18.75 | 145.33% | David Nierengarten63% | $53 → $46 | Upgrade | Underperform → Neutral | Get Alert |
| 05/18/2023 | TSVT | Buy Now | 2seventy bio | $4.99 | 421.04% | David Nierengarten63% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2023 | TSVT | Buy Now | 2seventy bio | $4.99 | 421.04% | David Nierengarten63% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | VOR | Buy Now | Vor Biopharma | $0.76 | 2281.58% | David Nierengarten63% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | David Nierengarten63% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | ANAB | Buy Now | AnaptysBio | $20.70 | 40.1% | David Nierengarten63% | → $29 | Reiterates | Neutral → Neutral | Get Alert |
| 05/10/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.10 | 217.07% | David Nierengarten63% | $5 → $13 | Upgrade | Neutral → Outperform | Get Alert |
| 05/09/2023 | XNCR | Buy Now | Xencor | $10.51 | 252.05% | David Nierengarten63% | $39 → $37 | Maintains | Outperform | Get Alert |
| 05/01/2023 | ISEE | Buy Now | IVERIC bio | — | — | David Nierengarten63% | $35 → $40 | Downgrade | Outperform → Neutral | Get Alert |
| 04/26/2023 | IRON | Buy Now | Disc Medicine | $45.42 | -20.74% | David Nierengarten63% | $32 → $36 | Maintains | Outperform | Get Alert |
| 04/21/2023 | ARGX | Buy Now | argenx | $614.76 | -29.73% | David Nierengarten63% | → $432 | Reiterates | → Outperform | Get Alert |
| 04/03/2023 | ISEE | Buy Now | IVERIC bio | — | — | David Nierengarten63% | → $29 | Reiterates | → Outperform | Get Alert |
| 03/31/2023 | STRO | Buy Now | Sutro Biopharma | $0.91 | 2098.04% | David Nierengarten63% | → $20 | Reiterates | → Outperform | Get Alert |
| 03/17/2023 | TSVT | Buy Now | 2seventy bio | $4.99 | 320.84% | David Nierengarten63% | $28 → $21 | Maintains | Outperform | Get Alert |
| 03/16/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | David Nierengarten63% | $29 → $25 | Maintains | Outperform | Get Alert |
| 03/16/2023 | NUVB | Buy Now | Nuvation Bio | $2.07 | 141.55% | David Nierengarten63% | → $5 | Reiterates | → Outperform | Get Alert |
| 03/16/2023 | ITOS | Buy Now | ITeos Therapeutics | $7.35 | 348.98% | David Nierengarten63% | $45 → $33 | Maintains | Outperform | Get Alert |
| 02/24/2023 | GBIO | Buy Now | Generation Bio | $0.42 | 3485.09% | David Nierengarten63% | $24 → $15 | Maintains | Outperform | Get Alert |
| 01/26/2023 | MGTA | Buy Now | Magenta Therapeutics | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 01/18/2023 | NUVL | Buy Now | Nuvalent | $73.48 | -46.92% | David Nierengarten63% | → $39 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.28 | 446.88% | David Nierengarten63% | → $7 | Downgrade | Outperform → Neutral | Get Alert |
| 01/04/2023 | IRON | Buy Now | Disc Medicine | $45.42 | -33.95% | David Nierengarten63% | → $30 | Initiates | → Outperform | Get Alert |
| 10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.10 | 46.34% | David Nierengarten63% | → $6 | Downgrade | Outperform → Neutral | Get Alert |
| 10/24/2022 | AGTC | Buy Now | Applied Genetic Techs | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 09/26/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $5.80 | 227.59% | David Nierengarten63% | $11 → $19 | Maintains | Outperform | Get Alert |
| 09/16/2022 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | $20 → $25 | Maintains | Outperform | Get Alert |
| 07/26/2022 | VOR | Buy Now | Vor Biopharma | $0.76 | 2281.58% | David Nierengarten63% | → $18 | Initiates | → Outperform | Get Alert |
| 06/27/2022 | EPZM | Buy Now | Epizyme | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/03/2022 | TPTX | Buy Now | Turning Point | — | — | David Nierengarten63% | $61 → $76 | Downgrade | Outperform → Neutral | Get Alert |
| 05/27/2022 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | 11.73% | David Nierengarten63% | $110 → $50 | Maintains | Outperform | Get Alert |
| 03/16/2022 | INZY | Buy Now | Inozyme Pharma | $0.96 | 2512.33% | David Nierengarten63% | $35 → $25 | Maintains | Outperform | Get Alert |
| 02/22/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | David Nierengarten63% | $34 → $24 | Maintains | Outperform | Get Alert |
| 01/10/2022 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | 52.39% | David Nierengarten63% | $66 → $50 | Maintains | Outperform | Get Alert |
| 12/15/2021 | FATE | Buy Now | Fate Therapeutics | $1.28 | 5681.25% | David Nierengarten63% | $71 → $74 | Upgrade | Neutral → Outperform | Get Alert |
| 12/14/2021 | GBIO | Buy Now | Generation Bio | $0.42 | 7309.18% | David Nierengarten63% | $36 → $31 | Maintains | Outperform | Get Alert |
| 11/08/2021 | TSVT | Buy Now | 2seventy bio | $4.99 | 701.6% | David Nierengarten63% | → $40 | Initiates | → Outperform | Get Alert |
| 11/01/2021 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | David Nierengarten63% | → $24 | Initiates | → Outperform | Get Alert |
| 09/17/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | David Nierengarten63% | $45 → $11 | Downgrade | Outperform → Neutral | Get Alert |
| 07/22/2021 | ARGX | Buy Now | argenx | $614.76 | -41.12% | David Nierengarten63% | $344 → $362 | Maintains | Outperform | Get Alert |
| 07/14/2021 | GBIO | Buy Now | Generation Bio | $0.42 | 8504.21% | David Nierengarten63% | $40 → $36 | Maintains | Outperform | Get Alert |
| 06/29/2021 | BEAM | Buy Now | Beam Therapeutics | $19.52 | 663.32% | David Nierengarten63% | $114 → $149 | Maintains | Outperform | Get Alert |
| 06/28/2021 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | 923.53% | David Nierengarten63% | $73 → $87 | Maintains | Neutral | Get Alert |
| 06/08/2021 | ARGX | Buy Now | argenx | $614.76 | -44.04% | David Nierengarten63% | $356 → $344 | Maintains | Outperform | Get Alert |
| 04/14/2021 | NVCR | Buy Now | NovoCure | $18.75 | 721.33% | David Nierengarten63% | $159 → $154 | Downgrade | Neutral → Underperform | Get Alert |
| 03/31/2021 | CMRX | Buy Now | Chimerix | $8.54 | 63.93% | David Nierengarten63% | → $14 | Initiates | → Outperform | Get Alert |
| 03/09/2021 | ANAB | Buy Now | AnaptysBio | $20.70 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $2.07 | 866.18% | David Nierengarten63% | → $20 | Initiates | → Outperform | Get Alert |
| 02/26/2021 | FATE | Buy Now | Fate Therapeutics | $1.28 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/10/2020 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | 43.25% | David Nierengarten63% | $33 → $47 | Maintains | Outperform | Get Alert |
| 11/09/2020 | CDAK | Buy Now | Codiak BioSciences | — | — | David Nierengarten63% | → $19 | Initiates | → Outperform | Get Alert |
| 10/27/2020 | SRRK | Buy Now | Scholar Rock Holding | $32.81 | 0.58% | David Nierengarten63% | $23 → $33 | Maintains | Outperform | Get Alert |
| 10/27/2020 | ANAB | Buy Now | AnaptysBio | $20.70 | 69.08% | David Nierengarten63% | $20 → $35 | Upgrade | Neutral → Outperform | Get Alert |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | David Nierengarten63% | $127 → $225 | Downgrade | Outperform → Neutral | Get Alert |
| 09/01/2020 | FRLN | Buy Now | Freeline Therapeutics | — | — | David Nierengarten63% | → $420 | Initiates | → Outperform | Get Alert |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | $0.96 | 3557.26% | David Nierengarten63% | → $35 | Initiates | → Outperform | Get Alert |
| 08/13/2020 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | 11.73% | David Nierengarten63% | $48 → $50 | Maintains | Outperform | Get Alert |
| 08/06/2020 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | $50 → $46 | Maintains | Outperform | Get Alert |
| 07/21/2020 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | David Nierengarten63% | → $25 | Initiates | → Outperform | Get Alert |
| 07/07/2020 | UMRX | Buy Now | Unum Therapeutics | — | — | David Nierengarten63% | $1 → $4 | Upgrade | Neutral → Outperform | Get Alert |
| 06/23/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | 356.14% | David Nierengarten63% | $375 → $390 | Maintains | Neutral | Get Alert |
| 05/13/2020 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | 7.26% | David Nierengarten63% | $45 → $48 | Maintains | Outperform | Get Alert |
| 05/05/2020 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | $11 → $12.5 | Downgrade | Outperform → Neutral | Get Alert |
| 05/01/2020 | NVCR | Buy Now | NovoCure | $18.75 | 316% | David Nierengarten63% | $80 → $78 | Maintains | Neutral | Get Alert |
| 04/03/2020 | FATE | Buy Now | Fate Therapeutics | $1.28 | 3103.13% | David Nierengarten63% | $38 → $41 | Maintains | Outperform | Get Alert |
| 03/17/2020 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | $14 → $11 | Maintains | Outperform | Get Alert |
| 03/04/2020 | UMRX | Buy Now | Unum Therapeutics | — | — | David Nierengarten63% | $7 → $1 | Downgrade | Outperform → Neutral | Get Alert |
| 03/02/2020 | BEAM | Buy Now | Beam Therapeutics | $19.52 | 63.93% | David Nierengarten63% | → $32 | Initiates | → Outperform | Get Alert |
| 02/27/2020 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | $67 → $55 | Maintains | Outperform | Get Alert |
| 02/14/2020 | FATE | Buy Now | Fate Therapeutics | $1.28 | 2478.13% | David Nierengarten63% | $29 → $33 | Maintains | Outperform | Get Alert |
| 02/14/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 96.9% | David Nierengarten63% | $71 → $75 | Maintains | Outperform | Get Alert |
| 02/14/2020 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | 88.24% | David Nierengarten63% | $21 → $16 | Downgrade | Outperform → Neutral | Get Alert |
| 01/24/2020 | EPZM | Buy Now | Epizyme | — | — | David Nierengarten63% | $24 → $30 | Maintains | Outperform | Get Alert |
| 01/17/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 01/17/2020 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | 28025% | David Nierengarten63% | → $90 | Downgrade | Outperform → Neutral | Get Alert |
| 01/16/2020 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | $17 → $14 | Maintains | Outperform | Get Alert |
| 01/07/2020 | ISEE | Buy Now | IVERIC bio | — | — | David Nierengarten63% | → $13 | Initiates | → Outperform | Get Alert |
| 12/03/2019 | BOLD | Buy Now | Audentes Therapeutics | $1.47 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/11/2019 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | $20 → $17 | Maintains | Outperform | Get Alert |
| 10/08/2019 | SWTX | Buy Now | SpringWorks Therapeutics | $44.75 | -26.26% | David Nierengarten63% | → $33 | Initiates | → Outperform | Get Alert |
| 09/10/2019 | TPTX | Buy Now | Turning Point | — | — | David Nierengarten63% | → $63 | Initiates | → Outperform | Get Alert |
| 08/08/2019 | MYOK | Buy Now | MyoKardia | — | — | David Nierengarten63% | $87 → $90 | Maintains | Outperform | Get Alert |
| 08/02/2019 | ARGX | Buy Now | argenx | $614.76 | -72.35% | David Nierengarten63% | $144 → $170 | Maintains | Outperform | Get Alert |
| 08/02/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 96.9% | David Nierengarten63% | → $75 | Assumes | → Outperform | Get Alert |
| 07/26/2019 | NVCR | Buy Now | NovoCure | $18.75 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/13/2019 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/03/2019 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 05/03/2019 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 03/11/2019 | TCRR | Buy Now | TCR2 Therapeutics | — | — | David Nierengarten63% | → $28 | Initiates | → Outperform | Get Alert |
| 03/01/2019 | ARGX | Buy Now | argenx | $614.76 | -76.58% | David Nierengarten63% | $131 → $144 | Maintains | Outperform | Get Alert |
| 02/27/2019 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | 5.26% | David Nierengarten63% | $210 → $90 | Maintains | Outperform | Get Alert |
| 02/11/2019 | FATE | Buy Now | Fate Therapeutics | $1.28 | 1540.62% | David Nierengarten63% | $19 → $21 | Maintains | Outperform | Get Alert |
| 12/07/2018 | XNCR | Buy Now | Xencor | $10.51 | 318.65% | David Nierengarten63% | $42 → $44 | Maintains | Outperform | Get Alert |
| 12/04/2018 | ARGX | Buy Now | argenx | $614.76 | -78.69% | David Nierengarten63% | $130 → $131 | Maintains | Outperform | Get Alert |
| 12/04/2018 | TSRO | Buy Now | Tesaro | — | — | David Nierengarten63% | $60 → $75 | Downgrade | Outperform → Neutral | Get Alert |
| 11/09/2018 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/07/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | David Nierengarten63% | → $40 | Upgrade | Underperform → Neutral | Get Alert |
| 11/05/2018 | ARGX | Buy Now | argenx | $614.76 | -78.85% | David Nierengarten63% | $125 → $130 | Maintains | Outperform | Get Alert |
| 11/02/2018 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | 135.29% | David Nierengarten63% | $36 → $20 | Downgrade | Outperform → Neutral | Get Alert |
| 10/29/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 131.03% | David Nierengarten63% | $90 → $88 | Maintains | Outperform | Get Alert |
| 10/22/2018 | STRO | Buy Now | Sutro Biopharma | $0.91 | 2098.04% | David Nierengarten63% | → $20 | Initiates | → Outperform | Get Alert |
| 10/08/2018 | BOLD | Buy Now | Audentes Therapeutics | $1.47 | 3437.41% | David Nierengarten63% | $49 → $52 | Maintains | Outperform | Get Alert |
| 09/17/2018 | FENC | Buy Now | Fennec Pharmaceuticals | $5.80 | 175.86% | David Nierengarten63% | $17 → $16 | Maintains | Outperform | Get Alert |
| 08/30/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 136.28% | David Nierengarten63% | $80 → $90 | Maintains | Outperform | Get Alert |
| 08/14/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | David Nierengarten63% | $18 → $20 | Maintains | Outperform | Get Alert |
| 08/06/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 110.03% | David Nierengarten63% | $71 → $80 | Maintains | Outperform | Get Alert |
| 07/27/2018 | NVCR | Buy Now | NovoCure | $18.75 | 113.33% | David Nierengarten63% | $33 → $40 | Maintains | Outperform | Get Alert |
| 07/16/2018 | ECYT | Buy Now | Endocyte | — | — | David Nierengarten63% | $15 → $21 | Maintains | Outperform | Get Alert |
| 06/25/2018 | ARGX | Buy Now | argenx | $614.76 | -81.46% | David Nierengarten63% | $93 → $114 | Maintains | Outperform | Get Alert |
| 05/29/2018 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | $20 → $22 | Maintains | Outperform | Get Alert |
| 05/24/2018 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/11/2018 | VYGR | Buy Now | Voyager Therapeutics | $3.44 | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 04/27/2018 | NVCR | Buy Now | NovoCure | $18.75 | 76% | David Nierengarten63% | $29 → $33 | Maintains | Outperform | Get Alert |
| 04/26/2018 | ARGX | Buy Now | argenx | $614.76 | -85.03% | David Nierengarten63% | $88 → $92 | Maintains | Outperform | Get Alert |
| 04/24/2018 | EPZM | Buy Now | Epizyme | — | — | David Nierengarten63% | $24 → $20 | Maintains | Outperform | Get Alert |
| 04/23/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | David Nierengarten63% | → $18 | Initiates | → Outperform | Get Alert |
| 04/16/2018 | BPMC | Buy Now | Blueprint Medicines | $87.02 | 21.81% | David Nierengarten63% | $98 → $106 | Maintains | Outperform | Get Alert |
| 03/19/2018 | XNCR | Buy Now | Xencor | $10.51 | 271.08% | David Nierengarten63% | $38 → $39 | Maintains | Outperform | Get Alert |
| 03/13/2018 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | 40525% | David Nierengarten63% | $110 → $130 | Maintains | Outperform | Get Alert |
| 03/12/2018 | VYGR | Buy Now | Voyager Therapeutics | $3.44 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/12/2018 | FENC | Buy Now | Fennec Pharmaceuticals | $5.80 | 193.1% | David Nierengarten63% | → $17 | Initiates | → Outperform | Get Alert |
| 03/06/2018 | FATE | Buy Now | Fate Therapeutics | $1.28 | 1384.37% | David Nierengarten63% | $10 → $19 | Maintains | Outperform | Get Alert |
| 02/20/2018 | ANAB | Buy Now | AnaptysBio | $20.70 | 629.47% | David Nierengarten63% | $142 → $151 | Maintains | Outperform | Get Alert |
| 01/16/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | David Nierengarten63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 11/20/2017 | PRTA | Buy Now | Prothena Corp | $9.99 | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 10/03/2017 | ECYT | Buy Now | Endocyte | — | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 09/14/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/29/2017 | KITE | Buy Now | Kite Pharma | — | — | David Nierengarten63% | — | Upgrade | Underperform → Neutral | Get Alert |
| 08/29/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | David Nierengarten63% | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/28/2017 | CMTA | Buy Now | Clementia Pharmaceuticals Inc. - Common Shares | — | — | David Nierengarten63% | → $26 | Initiates | → Outperform | Get Alert |
| 06/12/2017 | GTHX | Buy Now | G1 Therapeutics | — | — | David Nierengarten63% | → $31 | Initiates | → Outperform | Get Alert |
| 06/05/2017 | ECYT | Buy Now | Endocyte | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/09/2017 | KITE | Buy Now | Kite Pharma | — | — | David Nierengarten63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 04/19/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 96.9% | David Nierengarten63% | $80 → $75 | Downgrade | Outperform → Neutral | Get Alert |
| 03/28/2017 | TSRO | Buy Now | Tesaro | — | — | David Nierengarten63% | $164 → $174 | Reiterates | → Outperform | Get Alert |
| 03/23/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.09 | 110.03% | David Nierengarten63% | $88 → $80 | Reiterates | → Outperform | Get Alert |
| 03/15/2017 | TSRO | Buy Now | Tesaro | — | — | David Nierengarten63% | $200 → $164 | Reiterates | → Outperform | Get Alert |
| 03/09/2017 | ANAB | Buy Now | AnaptysBio | $20.70 | 35.27% | David Nierengarten63% | → $28 | Reiterates | → Outperform | Get Alert |
| 02/28/2017 | FATE | Buy Now | Fate Therapeutics | $1.28 | 446.88% | David Nierengarten63% | → $7 | Reiterates | → Outperform | Get Alert |
| 02/21/2017 | ANAB | Buy Now | AnaptysBio | $20.70 | 35.27% | David Nierengarten63% | → $28 | Initiates | → Outperform | Get Alert |
| 02/01/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | David Nierengarten63% | → $24 | Initiates | → Neutral | Get Alert |
| 01/27/2017 | NOVN | Buy Now | Novan | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/28/2016 | PNRA | Buy Now | Panera Bread | — | — | David Nierengarten63% | → $220 | Downgrade | Outperform → Neutral | Get Alert |
| 10/17/2016 | NOVN | Buy Now | Novan | — | — | David Nierengarten63% | — | Initiates | → Outperform | Get Alert |
| 09/20/2016 | WCIC | Buy Now | WCI Communities | — | — | David Nierengarten63% | → $21 | Initiates | → Neutral | Get Alert |
| 09/12/2016 | VTAE | Buy Now | Vitae Pharmaceuticals | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 08/22/2016 | MDVN | Buy Now | Medivation | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 08/22/2016 | MDVN | Buy Now | Medivation | — | — | David Nierengarten63% | → $81.5 | Downgrade | Outperform → Neutral | Get Alert |
| 08/18/2016 | CERU | Buy Now | Cerulean Pharma | — | — | David Nierengarten63% | $900 → $100 | Downgrade | Outperform → Neutral | Get Alert |
| 08/16/2016 | PSG | Buy Now | Performance Sports Group | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 08/15/2016 | BOLD | Buy Now | Audentes Therapeutics | $1.47 | 1260.54% | David Nierengarten63% | → $20 | Initiates | → Outperform | Get Alert |
| 07/25/2016 | OUTR | Buy Now | Space Acquisition Corp. I | — | — | David Nierengarten63% | → $45 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2016 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | 56150% | David Nierengarten63% | → $180 | Initiates | → Outperform | Get Alert |
| 07/15/2016 | STJ | Buy Now | St Jude Medical | — | — | David Nierengarten63% | $70 → $84 | Downgrade | Outperform → Neutral | Get Alert |
| 06/16/2016 | RLYP | Buy Now | Relypsa | — | — | David Nierengarten63% | $51 → $51 | Maintains | Outperform | Get Alert |
| 06/09/2016 | RLYP | Buy Now | Relypsa | — | — | David Nierengarten63% | → $51 | Maintains | Outperform | Get Alert |
| 05/31/2016 | NTLA | Buy Now | Intellia Therapeutics | $8.50 | — | David Nierengarten63% | — | Initiates | → Outperform | Get Alert |
| 05/11/2016 | EPRS | Buy Now | EPIRUS Biopharmaceuticals | — | — | David Nierengarten63% | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/30/2016 | ONCE | Buy Now | Spark Therapeutics | — | — | David Nierengarten63% | → $21 | Initiates | → Underperform | Get Alert |
| 01/20/2016 | TSRO | Buy Now | Tesaro | — | — | David Nierengarten63% | → $72 | Initiates | → Outperform | Get Alert |
| 11/23/2015 | MYOK | Buy Now | MyoKardia | — | — | David Nierengarten63% | → $22 | Initiates | → Outperform | Get Alert |
| 10/27/2015 | NVCR | Buy Now | NovoCure | $18.75 | 60% | David Nierengarten63% | → $30 | Initiates | → Outperform | Get Alert |
| 10/07/2014 | KPTI | Buy Now | Karyopharm Therapeutics | $5.70 | 777.19% | David Nierengarten63% | → $750 | Initiates | → Outperform | Get Alert |
| 10/28/2013 | FATE | Buy Now | Fate Therapeutics | $1.28 | 993.75% | David Nierengarten63% | → $14 | Initiates | → Outperform | Get Alert |
| 10/25/2013 | PRTA | Buy Now | Prothena Corp | $9.99 | 220.32% | David Nierengarten63% | $18 → $32 | Maintains | Outperform | Get Alert |
| 09/12/2013 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | → $49 | Initiates | → Outperform | Get Alert |
| 09/11/2013 | STML | Buy Now | Stemline Therapeutics | — | — | David Nierengarten63% | → $49 | Initiates | → Outperform | Get Alert |
| 06/27/2013 | PRTA | Buy Now | Prothena Corp | $9.99 | 80.18% | David Nierengarten63% | → $18 | Initiates | → Outperform | Get Alert |
| 06/27/2013 | EPZM | Buy Now | Epizyme | — | — | David Nierengarten63% | → $37 | Initiates | → Outperform | Get Alert |
| 03/27/2013 | ECYT | Buy Now | Endocyte, Inc. | — | — | David Nierengarten63% | $16 → $20 | Maintains | Outperform | Get Alert |
